Insmed launches four pivotal Phase 3 studies for TPIP in pulmonary diseases
INSM•Insmed launched four pivotal Phase 3 studies for TPIP in pulmonary diseases. Three studies have been initiated, and the fourth is expected to begin in the first half of 2027.
1. Trial launches
Insmed said it launched four pivotal Phase 3 studies for TPIP in pulmonary diseases. Three studies have been initiated, and the fourth is expected to begin in the first half of 2027.
